Palatin Technologies Inc. PTN
Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026
Palatin Technologies Inc. (PTN) is a healthcare company listed in the US with a market value of about $11M. In fiscal year 2026 it had revenue of $13M and net income of -$8M, a net margin of -63.5%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -1476%.
About Palatin Technologies
Palatin Technologies is listed in the US and classified in biotechnology: pharmaceutical preparations. Revenue went from $13M in 2015 to $13M in 2026, growth of about 0.2% a year. It was profitable in 3 of the last 10 years in our data. Its share count fell by 74% over three years (buybacks). It spends 94% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Share count down over 3 years (buybacks)
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $0 | $4M | $5M | $1M | -$188597 | $117989 | $60M | $67M | $67M |
| Net income | -$8M | -$17M | -$30M | -$24M | -$36M | -$34M | -$22M | $36M | $25M | $25M |
| Free cash flow | -$14M | -$21M | -$32M | -$30M | -$30M | -$99360 | $41M | -$22M | $2M | $13M |
| EPS (diluted) | $-2.96 | $-32.15 | $-101.16 | $-2.21 | — | $-0.14 | $-0.10 | $0.16 | $0.12 | $0.12 |
| Net margin | -63.5% | — | -662.3% | -495.2% | -2465.1% | 17813.9% | -19006.9% | 59.3% | 36.8% | 36.8% |
| ROIC | -99.1% | — | -4106.0% | — | -221.5% | -51.8% | -22.9% | 27.9% | 61.6% | 223.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Palatin Technologies pay a dividend?
Not currently.
Is Palatin Technologies a good stock to buy?
We do not give buy or sell advice. Palatin Technologies scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.